TNF and type 2 diabetes mellitus: Subclinical inflammation plays a critical role in the pathogenesis of Type 2 diabetes and insulin resistance syndrome, whereby pro-inflammatory cytokines such as TNF-α levels are increased in obesity and Type 2 diabetes [27].